Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Unlike full-length growth hormone, which can cause edema (fluid retention), joint pain, carpal tunnel syndrome, glucose elevation, and increased IGF-1, AOD-9604 demonstrates none of these effects in clinical trials
The peptide was originally developed for obesity treatment and has been studied for its ability to stimulate fat breakdown
In the phase 3a SCALE trials, participants body weight loss with liraglutide 3.0 mg treatment was 6.08.0% reported using a LOCF-based analysis method [26, 27, 32] and 4.97.4% using MI [37]
No prior authorizations, no claim denials, no waiting on approvals
If you are concerned about pain or discomfort, please inform our team, and they can discuss options such as numbing creams or techniques to further minimize any potential discomfort
Uofmhealth.org
US$ 27.27
US$ 29.53
US$ 26.21
